Acacia Research Corporation (ACTG) 13D/13G Filings for Theravance Biopharma, Inc. (TBPH)

Acacia Research Corporation 13D and 13G filings for Theravance Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2020-06-11
11:43 am
Unchanged		2020-06-0413GTheravance Biopharma, Inc.
TBPH		ACACIA RESEARCH CORP
ACTG		0
0.000%		0
(Unchanged)		Filing